by Theaids2031Consortium (Author)
AIDS is a continuing worldwide health crisis. Over 25,000,000 people have died from AIDS, and more than 33,000,000 are infected today. While treatments in the developed world have moved AIDS from a fatal to a chronic, highly expensive disease, it remains the sixth greatest cause of death globally and most of those infected in the developing world don't have access to treatments. Here, the AIDS 2031 Commission's experts report on the first 50 years of the AIDS pandemic: the 30 years that have passed since AIDS was first diagnosed, and the prospects and best plans to address the ongoing worldwide AIDS epidemic over the coming 20 years. The authors address the entire scope of the pandemic: basic science, public health, funding, treatment options, and social and societal impacts and review the full range of possible and recommended responses over the next two decades. They carefully assess the progress that has been made, and both persistent and emerging challenges. Written to be easily understandable by all readers, this book is the single best source of reliable information on where the pandemic stands today, where it's headed, and what can be done to create better outcomes between now and 2031.
Format: Hardcover
Pages: 224
Edition: 1
Publisher: Financial Times/ Prentice Hall
Published: 10 Dec 2010
ISBN 10: 0132172593
ISBN 13: 9780132172592
Book Overview: Over 25,000,000 people have died from AIDS, and more than 33,000,000 are infected today. While treatments in the developed world have moved AIDS from a fatal to a chronic, highly expensive disease, it remains the sixth greatest cause of death globally and most of those infected in the developing world don't have access to treatments. In short, AIDS is a continuing worldwide health crisis. In AIDS in an Uncertain World, the AIDS 2031 Commission's experts report on the first 50 years of the AIDS pandemic: the 30 years that have passed since AIDS was first diagnosed, and the prospects and best plans to address the ongoing worldwide AIDS epidemic over the coming 20 years. The authors address the entire scope of the pandemic: basic science, public health, funding, treatment options, and social and societal impacts and review the full range of possible and recommended responses over the next two decades. They carefully assess the progress that has been made, and both persistent and emerging challenges. Written to be easily understandable by all readers, this book is the single best source of reliable information on where the pandemic stands today, where it's headed, and what can be done to create better outcomes between now and 2031.
The aids2031 Consortium includes nine thematic working groups on the topics of modeling, science and technology, social drivers, the programmatic response, financing, communication, leadership, a special look at hyperendemic countries (Southern Africa), and countries in rapid economic transition (focusing on China, India, Indonesia, Malaysia, and Thailand). These nine groups, along with a group of aids2031 young leaders, engaged over 500 people around the world in discussions, debates, and issue-specific analyses on the current and future state of AIDS.
The work of the aids2031 Consortium and its working groups is led by the Steering Committee listed here:
Zackie Achmat, Founder, Treatment Action Campaign, South Africa
Ricardo Baruch, Global Youth Coalition on HIV/AIDS Taskforce, Mexico
Stefano Bertozzi, Director, HIV and Tuberculosis, Global Health Program, Bill & Melinda Gates Foundation, and Chair of the aids2031 Steering Committee
Myung-Hwan Cho, President, AIDS Society of Asia and the Pacific, and Professor, Konkuk University, South Korea
Achmat Dangor, CEO, Nelson Mandela Foundation, South Africa
Paul Delay, Deputy Executive Director, UNAIDS, Switzerland
Alex deWaal, Program Director, HIV/AIDS and Social Transformation, Social Science Research Council, USA
Chris Elias, President, Program for Appropriate Technology in Health (PATH), USA
David de Ferranti, Executive Director, Global Health Initiative, Brookings Institution, USA
William Fisher, Director, Department of International Development, Community and Environment, Clark University, USA
Geoffrey Garnett, Professor, Imperial College London, UK
Denise Gray-Felder, President, Communication for Social Change Consortium, USA
Geeta Rao Gupta, Senior Fellow at the Bill & Melinda Gates Foundation and former President, International Center for Research on Women, USA
Rob Hecht, Principal and Managing Director, Results for Development, USA
Heidi Larson, Executive Director aids2031 and Senior Lecturer at the London School of Hygiene and Tropical Medicine, UK
Callisto Madavo, Professor, Georgetown University, USA
Michael Merson, Director, Duke University Global Health Institute, USA
Sigrun Mogedal, Ambassador on HIV/AIDS, Ministry of Foreign Affairs, Norway
Prasada Rao, Senior Advisor to the Executive Director of UNAIDS and former UNAIDS Regional Director for Asia and the Pacific
Leonardo Simao, Chief Executive, Joachim Chissano Foundation, Mozambique
As Sy, UNICEF Regional Director for East and Southern Africa, and former UNAIDS Director of Partnerships and External Relations
Ex officio members:
Robert Hemmer, National Service of Infectious Diseases, Centre Hospitalier de Luxembourg
Peter Piot, Director of the London School of Hygiene and Tropical Medicine, and former UNAIDS Executive Director
Todd Summers, Senior Advisor for Global Health at ONE, formerly Senior Policy Officer for Global Health, Bill & Melinda Gates Foundation, USA
Writing team:
Stefano Bertozzi, William Fisher, Michael T. Isbell, Lindsay Knight, Heidi Larson, and Peter Piot